Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

This article explores how pharma regulatory bodies such as FDA, EMA, and WHO shape global GMP compliance. It highlights inspection trends, data integrity requirements, and harmonized regulatory frameworks that drive pharmaceutical quality systems and inspection readiness worldwide.
This article explains how CSV Documentation supports GMP compliance in computerized systems, focusing on validation traceability, IQ OQ PQ documentation, and data integrity requirements aligned with FDA 21 CFR Part 11 and EU Annex 11 expectations.
This article explains how data in GMP is controlled across its lifecycle, focusing on pharmaceutical data integrity, audit trail review, and electronic records compliance. It highlights regulatory expectations under ALCOA+ principles, FDA guidance, and Annex 11 requirements for inspection readiness.
This article explains how train validation test failures impact GMP inspection outcomes, focusing on data validation strategy GMP, audit trail control, and validation dataset design GMP. It highlights how weak validation logic increases compliance and data integrity risks in regulated
This article explains the regulatory relationship between CMC and GMP, highlighting key differences, inspection findings, and compliance expectations. It shows how documentation, validation, and manufacturing control connect to FDA and global pharmaceutical quality system requirements.
This article explains how equipment qualification supports GMP compliance through structured validation stages. It highlights common inspection findings, documentation requirements, and risk-based validation lifecycle approach to help reduce validation deviation trends pharma inspections and improve audit readiness.
This article explains how EU GMP Annex 1 defines sterile manufacturing requirements, focusing on contamination control strategy, cleanroom classification, and aseptic processing. It highlights GMP inspection findings and shows how facilities can improve compliance and inspection readiness effectively.
This article explains computerized system validation in regulated environments, focusing on CSV life cycle controls, data integrity compliance, and risk-based validation principles. It also highlights inspection expectations, supplier assessment guidance, and audit trail requirements under FDA Part 11 and EU
This article breaks down the practical steps for cleaning validation protocol pharma, from defining acceptance criteria and worst-case scenarios to swab and rinse sampling. Learn how to reduce inspection findings and ensure GMP-compliant equipment cleaning validation lifecycle.
Explore how pharmaceutical water system validation safeguards product quality and prevents microbial contamination. This article highlights best practices for monitoring, sanitization, and sampling plans, ensuring compliance with GMP standards and minimizing risks identified during regulatory inspections